Skip to content
DeepViews

West Pharmaceutical Services, Inc. (WST) — 分析摘要

West Pharmaceutical Services, Inc.(WST)的市值为24.36十亿美元,最近一年的营收同比增长了+6.3%。净利润率为16.1%。当前市盈率为43.1倍。

核心要点

  • 营收同比变化+6.3%
  • 净利润率16.1%
  • 市盈率43.1倍

与SURGICAL & MEDICAL INSTRUMENTS & APPARATUS板块的其他公司相比,WST的营收增长为+6.3%,市盈率为43.1倍。

[XNYS]

West Pharmaceutical Services, Inc. (WST)

$337.47

更新 — ET · 市场数据 POLYGON · 财务数据 SEC EDGAR

市值
$24.36B
企业价值
$24.12B
市盈率
43.1
股息率
0.26%
EV/EBITDA
28.0
公司简介
关于
关于 West Pharmaceutical Services, Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

行业

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

员工人数

10,800

总部

EXTON, PA

Exchange

XNYS

官网
Source: Polygon.io
评分
竞争壁垒
竞争壁垒
53
窄护城河

基于 4 年财务数据的系统性竞争优势评估

此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。

市场信号
估值
盈利
内部人交易
内部人备案活动

首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。

加载 SEC 内部人备案数据...
超级投资者
财务健康
财务健康

资本结构

总权益$2990.20M
总债务$202.90M
债务权益比0.07
现金及等价物$435.80M

现金流

经营现金流$662.20M
自由现金流$436.90M
自由现金流率13.13%
P/FCF 比率55.75
Source: Polygon.io · SEC EDGAR
股息
股息

年度每股股息

$0.88

股息收益率

0.26%

季度
最近除息日: 2026-07-29

股息历史

2026-07-29
CD$0.2200
2026-04-29
CD$0.2200
2026-01-28
CD$0.2200
2025-11-12
CD$0.2200
Source: Polygon.io
最新资讯
Recent News

免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。